Kolexia
Allouache Djalila Oncologie médicale
Allouache Djalila
Oncologie médicale
Centre François-Baclesse
Caen, France
40 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Métastase tumorale Fatigue Tumeurs du cerveau Nausée Troubles de la veille et du sommeil Complications tumorales de la grossesse Vomissement

Collaborateurs

Voir plus
Levy Christelle
Levy Christelle
Centre François-Baclesse, Caen, France
Hrab Ioana
Hrab Ioana
Centre François-Baclesse, Caen, France
Segura-Djezzar Carine
Segura-Djezzar Carine
Centre François-Baclesse, Caen, France
Emile George
Emile George
Centre François-Baclesse, Caen, France

Industries

Voir plus
Lilly
9 collaboration(s)
Dernière en 2023
Novartis
6 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
255P Prognostic stratification capacity of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
112P Correlation between HER2-negative status and risk of recurrence according to PAM50 score
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023
Modifications of oscillations related to sleep-dependent memory consolidation in breast cancer patients
Abstracts of the 26th Conference of the European Sleep Research Society, 27–30 September 2022, Athens, Greece   20 octobre 2022
104P HELENA: Study of HER2-low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer
Abstract Book of ESMO Breast Cancer 2022, Berlin, Germany, 03-05 May 2022   01 mai 2022
Sleep macro- and microstructure in breast cancer survivors.
Scientific reports   15 février 2022
148P Phase III study of everolimus or placebo in addition to adjuvant hormone therapy for high risk early breast cancer: Subgroup analysis of the UCBG UNIRAD trial
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Corrigendum to ‘VP1-2021: Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer’: Annals of Oncology 2021;32:574-575
Annals of oncology : official journal of the European Society for Medical Oncology   01 juin 2021
117P Pretherapeutic neutrophil-lymphocyte ratio as prognostic and predictive factors in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors
Abstract Book of the ESMO Breast Cancer Virtual Congress 202105-08 May 2021   01 mai 2021
Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer
Annals of oncology : official journal of the European Society for Medical Oncology   01 avril 2021
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019